Avau, Bert http://orcid.org/0000-0002-9160-084X
Van Remoortel, Hans
Laermans, Jorien
Bekkering, Geertruida
Fergusson, Dean
Georgsen, Jørgen
Manzini, Paola Maria
Ozier, Yves
De Buck, Emmy
Compernolle, Veerle
Vandekerckhove, Philippe
Funding for this research was provided by:
European Blood Alliance
Foundation for Scientific Research of the Belgian Red Cross
Article History
Accepted: 18 May 2021
First Online: 8 July 2021
Declarations
:
: Funding for this project has been provided partly through an Agreement with the European Blood Alliance (EBA) and partly by the Foundation for Scientific Research of the Belgian Red Cross. The contents of this document do not necessarily reflect the views and policies of the EBA, nor does mentioning of trade names or commercial products constitute endorsement or recommendation of use.
: Relevant financial conflicts of interest directly related to this review: HV, JL, BA, EDB, GB, DF, JG, VC, YO and PV declared not having any relevant direct financial conflict of interest. PMM received personal fees from Ethos Srl (Advisory Board on PBM) and SUMMEET Srl (Speaker in a meeting on PBM). Relevant financial conflicts of interest not directly related to this review: HV, JL, BA, EDB, VC and PV are employees of Belgian Red Cross-Flanders, which is responsible for supplying adequate quantities of safe blood products to hospitals in Flanders and Brussels on a continuous basis and is funded by the Ministry of Social Affairs. Belgian Red Cross-Flanders received a grant from the European Blood Alliance to conduct this review. GB, DF, JG and YO declared not having any other financial conflicts of interest. PMM received personal fees from Editree Srl (creation of training course on porphyria), Eleuthera Srl (AHP Advisory Board), Collage SpA (speaker in a meeting on erythrocytosis), IQVIA (Advisory Board on porphyria), Alnylam (Advisory Board on porphyria). Relevant intellectual conflicts of interest: HV, JL, BA, GB, DF, PMM, YO, EDB, VC and PV declared not having any intellectual conflict of interest. JG declared to be involved in The Danish Health Authority—National Clinical Guideline—Indication for Transfusion with Blood Components—Copenhagen 2018—ExternalRef removed
: All data generated or analysed during this study are included in this published article and its supplementary information files.
: BA: Investigation, formal analysis, writing—original draft, visualization. HVR: Conceptualization, investigation, formal analysis, writing—original draft, visualization, supervision, project administration, funding acquisition. JL: Validation, writing—review and editing. GB: Validation, writing—review and editing. DF: Validation, writing—review and editing. PMM: Validation, writing—review and editing. JG: Validation, writing—review and editing. YO: Validation, writing—review and editing. EDB: Conceptualization, writing—review and editing, supervision. VC: Conceptualization, writing—review and editing. PV: Conceptualization, resources, writing—review and editing, supervision.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.